APA

Sax P. E., Wohl D., Yin M. T., Post F., DeJesus E., Saag M., Pozniak A., Thompson M., Podzamczer D., Molina J. M., Oka S., Koenig E., Trottier B., Andrade-Villanueva J., Crofoot G., Custodio J. M., Plummer A., Zhong L., Cao H., Martin H., Callebaut C., Cheng A. K., Fordyce M. W. & McCallister S. (20150716). Tenofovir alafenamide versus tenofovir disoproxil fumarate, coformulated with elvitegravir, cobicistat, and emtricitabine, for initial treatment of HIV-1 infection: two randomised, double-blind, phase 3, non-inferiority trials. : Lancet (London, England).

Chicago

Sax Paul E, Wohl David, Yin Michael T, Post Frank, DeJesus Edwin, Saag Michael, Pozniak Anton, Thompson Melanie, Podzamczer Daniel, Molina Jean Michel, Oka Shinichi, Koenig Ellen, Trottier Benoit, Andrade-Villanueva Jaime, Crofoot Gordon, Custodio Joseph M, Plummer Andrew, Zhong Lijie, Cao Huyen, Martin Hal, Callebaut Christian, Cheng Andrew K, Fordyce Marshall W and McCallister Scott. 20150716. Tenofovir alafenamide versus tenofovir disoproxil fumarate, coformulated with elvitegravir, cobicistat, and emtricitabine, for initial treatment of HIV-1 infection: two randomised, double-blind, phase 3, non-inferiority trials. : Lancet (London, England).

Harvard

Sax P. E., Wohl D., Yin M. T., Post F., DeJesus E., Saag M., Pozniak A., Thompson M., Podzamczer D., Molina J. M., Oka S., Koenig E., Trottier B., Andrade-Villanueva J., Crofoot G., Custodio J. M., Plummer A., Zhong L., Cao H., Martin H., Callebaut C., Cheng A. K., Fordyce M. W. and McCallister S. (20150716). Tenofovir alafenamide versus tenofovir disoproxil fumarate, coformulated with elvitegravir, cobicistat, and emtricitabine, for initial treatment of HIV-1 infection: two randomised, double-blind, phase 3, non-inferiority trials. : Lancet (London, England).

MLA

Sax Paul E, Wohl David, Yin Michael T, Post Frank, DeJesus Edwin, Saag Michael, Pozniak Anton, Thompson Melanie, Podzamczer Daniel, Molina Jean Michel, Oka Shinichi, Koenig Ellen, Trottier Benoit, Andrade-Villanueva Jaime, Crofoot Gordon, Custodio Joseph M, Plummer Andrew, Zhong Lijie, Cao Huyen, Martin Hal, Callebaut Christian, Cheng Andrew K, Fordyce Marshall W and McCallister Scott. Tenofovir alafenamide versus tenofovir disoproxil fumarate, coformulated with elvitegravir, cobicistat, and emtricitabine, for initial treatment of HIV-1 infection: two randomised, double-blind, phase 3, non-inferiority trials. : Lancet (London, England). 20150716.